Log in to save to my catalogue

A novel 4-aminoquinoline chemotype with multistage antimalarial activity and lack of cross-resistanc...

A novel 4-aminoquinoline chemotype with multistage antimalarial activity and lack of cross-resistanc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_968faf820f6f4693b401c6d86b0c60ef

A novel 4-aminoquinoline chemotype with multistage antimalarial activity and lack of cross-resistance with PfCRT and PfMDR1 mutants

About this item

Full title

A novel 4-aminoquinoline chemotype with multistage antimalarial activity and lack of cross-resistance with PfCRT and PfMDR1 mutants

Publisher

United States: PLoS

Journal title

PLoS pathogens, 2024-10, Vol.20 (10), p.e1012627

Language

English

Formats

Publication information

Publisher

United States: PLoS

More information

Scope and Contents

Contents

Copyright: © 2024 Ferreira et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Artemisinin-based combination therapy (ACT) is the mainstay of effective trea...

Alternative Titles

Full title

A novel 4-aminoquinoline chemotype with multistage antimalarial activity and lack of cross-resistance with PfCRT and PfMDR1 mutants

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_968faf820f6f4693b401c6d86b0c60ef

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_968faf820f6f4693b401c6d86b0c60ef

Other Identifiers

ISSN

1553-7374,1553-7366

E-ISSN

1553-7374

DOI

10.1371/journal.ppat.1012627

How to access this item